Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993150priorityCriticalpatent/ECSP993150A/en
Publication of ECSP993150ApublicationCriticalpatent/ECSP993150A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere al uso de ciertos derivados de pirido [1,2-a]- pirizina, también descritos como compuestos bis-azabicíclicos y definidos por la fórmula (I) de este documento, en el tratamiento de la enfermedad de parkinson, el trastorno de hiperactividad con déficit de atención y microademonas en mamíferos, y a composiciones relacionadas.The present invention relates to the use of certain pyrido [1,2-a] -pyrizine derivatives, also described as bis-azabicyclic compounds and defined by formula (I) herein, in the treatment of Parkinson's disease, attention deficit hyperactivity disorder and mammalian mammals, and related compositions.
ECSP9931501999-09-211999-09-21
PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON'S DISEASE, ADHD AND MICROADENOMAS
ECSP993150A
(en)
SMALL MOLECULES, THE INTERMEDIARIES FOR THEIR SYNTHESIS, THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE TO PREPARE A MEDICINAL PRODUCT INTENDED FOR TREATMENT OR PROPHYLAXIS OF INFLAMMATORY DISEASES OR MEDIATIONED BY IMMUNE CELLS
SUBSTITUTED PIRAZOLO-QUINAZOLINA DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. PROCESS FOR THE PREPARATION AND USE OF THE SAME AS ANTICANCER AGENTS.